EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 67 filers reported holding EPIZYME INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $8,499,000 | +41.4% | 478,793 | -0.1% | 0.02% | +47.1% |
| Q4 2017 | $6,012,000 | -49.9% | 479,053 | -23.9% | 0.02% | -51.4% |
| Q3 2017 | $11,995,000 | +23.3% | 629,666 | -2.2% | 0.04% | +20.7% |
| Q2 2017 | $9,726,000 | +678.1% | 644,081 | +725.3% | 0.03% | +625.0% |
| Q4 2015 | $1,250,000 | -19.3% | 78,041 | -35.2% | 0.00% | -20.0% |
| Q3 2015 | $1,548,000 | -80.4% | 120,363 | -63.4% | 0.01% | -76.2% |
| Q2 2015 | $7,892,000 | +382.1% | 328,871 | +277.4% | 0.02% | +425.0% |
| Q1 2015 | $1,637,000 | -21.9% | 87,134 | -21.6% | 0.00% | -20.0% |
| Q4 2014 | $2,097,000 | -89.9% | 111,114 | -85.5% | 0.01% | -90.4% |
| Q3 2014 | $20,792,000 | -8.9% | 766,965 | +4.6% | 0.05% | +100.0% |
| Q2 2014 | $22,826,000 | +841.7% | 733,502 | +589.1% | 0.03% | +333.3% |
| Q1 2014 | $2,424,000 | +9.1% | 106,436 | -0.3% | 0.01% | +20.0% |
| Q4 2013 | $2,221,000 | -49.1% | 106,772 | -1.9% | 0.01% | -50.0% |
| Q3 2013 | $4,367,000 | – | 108,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,558,108 | $27,656,000 | 9.20% |
| Palo Alto Investors LP | 6,895,075 | $122,388,000 | 5.23% |
| NEA Management Company, LLC | 6,460,851 | $114,680,000 | 5.10% |
| Foresite Capital Management III, LLC | 998,278 | $17,719,000 | 3.86% |
| ORACLE INVESTMENT MANAGEMENT INC | 396,325 | $7,035,000 | 1.70% |
| Redmile Group, LLC | 2,011,989 | $35,713,000 | 1.38% |
| Rock Springs Capital Management LP | 1,275,000 | $22,631,000 | 0.96% |
| Virtus ETF Advisers LLC | 59,330 | $1,053,000 | 0.91% |
| Sio Capital Management, LLC | 72,826 | $1,293,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 960,970 | $17,057,000 | 0.59% |